Spero Therapeutics is a dedicated biopharmaceutical company that aims to provide differentiated medicines to patients suffering from serious rare orphan diseases and life-threatening infections. Founded with the mission to address the growing global threat of antibiotic resistance, Spero is committed to developing innovative therapeutic approaches for the treatment of multi-drug resistant bacterial infections. With a focus on responsible use, stewardship, and stability, Spero's vision is to deliver effective therapies that have a lasting impact on patients' lives.

The organization is built on foundations of stability and momentum and is driven by a commitment to excellence. Guided by the Italian word spero, meaning hope, Spero Therapeutics embraces the belief that hope can be brought to patients and their families who are affected by serious infections. The company's world-class team of biotechnology and biopharmaceutical experts relentlessly pursues novel treatment approaches for bacterial infections.

With a multi-asset, clinical-stage pipeline, Spero is at the forefront of pioneering infectious disease treatments. They actively seek collaborations and partnerships to further their scientific expertise and secure funding support. Join Spero Therapeutics in their mission to make a difference and bring hope to patients in need